The brief

Analyst view

• Boston Scientific acquired Advanced Bionics 2004 and Intelect Medical 2011 to enter neuromodulation.
• Vercise Genus launched Jan 2021, features 16-contact directional leads with >200% directional span.
• Second-largest neuromodulation player; competes with Medtronic and Abbott in DBS and SCS.

Technical approach

As reported

Directional leads

Advanced electrode geometry

16-contact Vercise leads deliver stimulation in specific directions, not all directions equally.

Image-guided programming

Illumina 3D imaging

System integrates 3D brain anatomy imaging with programming for optimized electrode placement.

Flexible power

Rechargeable and non-rechargeable

Offers both rechargeable and non-rechargeable systems for different patient preferences.